Sushant H. Meshram

Nagpur, MH, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Correlation of the Six-Minute Walk Test, Diffusing Capacity for Carbon Monoxide, and Pulmonary Function Parameters in Patients With Interstitial Lung Disease: A Cross-Sectional Study.

Correlation of the Six-Minute Walk Test, Diffusing Capacity for Carbon Monoxide, and Pulmonary Function Parameters in Patients With Interstitial Lung Disease: A Cross-Sectional Study.

Journal: Cureus
Published: October 19, 2025

A Study to Assess the Association Between Sleep and Migraine.

A Study to Assess the Association Between Sleep and Migraine.

Journal: Cureus
Published: March 30, 2025

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.

Journal: Human vaccines & immunotherapeutics
Published: March 21, 2024

Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.

Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.

Journal: JAMA pediatrics
Published: July 31, 2023

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.

Journal: The Lancet regional health. Southeast Asia
Published: August 10, 2022

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.

Journal: EClinicalMedicine
Published: August 19, 2021

Obstructive sleep apnea, intermittent hypoxemia and prothrombotic biomarkers.

Obstructive sleep apnea, intermittent hypoxemia and prothrombotic biomarkers.

Journal: Sleep science (Sao Paulo, Brazil)
Published: February 10, 2021

Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.

Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 16, 2018

Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients.

Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients.

Journal: Advanced biomedical research
Published: May 19, 2017

Tuberculosis screening among persons with diabetes mellitus in Pune, India.

Tuberculosis screening among persons with diabetes mellitus in Pune, India.

Journal: BMC infectious diseases
Published: December 25, 2016

Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study.

Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study.

Journal: BMJ open
Published: February 27, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026